Thalidomide
Top Cited Papers
Open Access
- 29 May 2004
- journal article
- review article
- Published by Elsevier BV in The Lancet
- Vol. 363 (9423), 1802-1811
- https://doi.org/10.1016/s0140-6736(04)16308-3
Abstract
No abstract availableThis publication has 120 references indexed in Scilit:
- Thalidomide as initial therapy for early-stage myelomaLeukemia, 2003
- Cancer Statistics, 2003CA: A Cancer Journal for Clinicians, 2003
- Immunomodulatory drug CC-5013 overcomes drug resistance and is well tolerated in patients with relapsed multiple myelomaBlood, 2002
- Thalidomide in the Treatment of Relapsed Multiple MyelomaMayo Clinic Proceedings, 2000
- Antitumor Activity of Thalidomide in Refractory Multiple MyelomaThe New England Journal of Medicine, 1999
- Treatment of cutaneous and pulmonary sarcoidosis with thalidomideJournal of the American Academy of Dermatology, 1995
- Thalidomide is an inhibitor of angiogenesis.Proceedings of the National Academy of Sciences of the United States of America, 1994
- Thalidomide exerts its inhibitory action on tumor necrosis factor alpha by enhancing mRNA degradation.The Journal of Experimental Medicine, 1993
- Thalidomide for systemic lupus erythematosusThe Lancet, 1992
- Treatment of Behçet's disease with thalidomideClinical Rheumatology, 1986